Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes app
Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes